Dr. Amatruda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
480 Osborne Rd NE
Ste 220
Fridley, MN 55432Phone+1 763-786-1620Fax+1 763-780-3099
Education & Training
California Institute of TechnologyPost-Doctoral Fellowship, Biology, Signal Transduction, 1985 - 1992
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1982 - 1985
UCSF Health1978 - 1981
Yale School of MedicineClass of 1978
Certifications & Licensure
MN State Medical License 1992 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery Start of enrollment: 2006 Oct 01
- Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma Start of enrollment: 2013 Jul 12
Publications & Presentations
PubMed
- Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III tria...Laurie E McLouth, Yue Zheng, Stephanie Smith, F Stephen Hodi, Uma N Rao
Quality of Life Research. 2023-01-01 - 1 citationsEffect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.Phuong L Mai, Austin Miller, Amanda Black, Roni T Falk, John F Boggess
American Journal of Obstetrics and Gynecology. 2022-07-01 - 42 citationsBiodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanomaRobert H.I. Andtbacka, Thomas Amatruda, John Nemunaitis, Jonathan S. Zager, John Walker
Ebiomedicine. 2019-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
